Global Sleep Disorder Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 148832
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 120
  • list Pharmaceuticals and Healthcare

Sleep disorders result in a lack of deep and restorative sleep.

Scope of the Report:

The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times.

The global Sleep Disorder Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sleep Disorder Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Sleep Disorder Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Sleep Disorder Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers

Sanofi

Sunovion Pharmaceuticals

Takeda Pharmaceutical

Somaxon Pharmaceuticals

Vanda Pharmaceuticals

Eli Lilly

GSK

Neurim Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Insomnia

Excessive Sleep

Disturbed Sleep

Market Segment by Applications, can be divided into

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Sleep Disorder Therapeutics Market Overview

1.1 Product Overview and Scope of Sleep Disorder Therapeutics

1.2 Classification of Sleep Disorder Therapeutics by Types

1.2.1 Global Sleep Disorder Therapeutics Revenue Comparison by Types (2017-2023)

1.2.2 Global Sleep Disorder Therapeutics Revenue Market Share by Types in 2017

1.2.3 Insomnia

1.2.4 Excessive Sleep

1.2.5 Disturbed Sleep

1.3 Global Sleep Disorder Therapeutics Market by Application

1.3.1 Global Sleep Disorder Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacies

1.3.3 Online Pharmacies

1.3.4 Retail Pharmacies

1.4 Global Sleep Disorder Therapeutics Market by Regions

1.4.1 Global Sleep Disorder Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Sleep Disorder Therapeutics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Sleep Disorder Therapeutics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sleep Disorder Therapeutics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Sleep Disorder Therapeutics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sleep Disorder Therapeutics Status and Prospect (2013-2023)

1.5 Global Market Size of Sleep Disorder Therapeutics (2013-2023)

2 Manufacturers Profiles

2.1 Sanofi

2.1.1 Business Overview

2.1.2 Sleep Disorder Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Sanofi Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sunovion Pharmaceuticals

2.2.1 Business Overview

2.2.2 Sleep Disorder Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.3 Takeda Pharmaceutical

2.3.1 Business Overview

2.3.2 Sleep Disorder Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Takeda Pharmaceutical Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Somaxon Pharmaceuticals

2.4.1 Business Overview

2.4.2 Sleep Disorder Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Vanda Pharmaceuticals

2.5.1 Business Overview

2.5.2 Sleep Disorder Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Vanda Pharmaceuticals Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.6 Eli Lilly

2.6.1 Business Overview

2.6.2 Sleep Disorder Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Eli Lilly Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.7 GSK

2.7.1 Business Overview

2.7.2 Sleep Disorder Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 GSK Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.8 Neurim Pharmaceuticals

2.8.1 Business Overview

2.8.2 Sleep Disorder Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Neurim Pharmaceuticals Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Sleep Disorder Therapeutics Market Competition, by Players

3.1 Global Sleep Disorder Therapeutics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Sleep Disorder Therapeutics Players Market Share

3.2.2 Top 10 Sleep Disorder Therapeutics Players Market Share

3.3 Market Competition Trend

4 Global Sleep Disorder Therapeutics Market Size by Regions

4.1 Global Sleep Disorder Therapeutics Revenue and Market Share by Regions

4.2 North America Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

4.3 Europe Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

4.5 South America Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Sleep Disorder Therapeutics Revenue by Countries

5.1 North America Sleep Disorder Therapeutics Revenue by Countries (2013-2018)

5.2 USA Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

5.3 Canada Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

5.4 Mexico Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Sleep Disorder Therapeutics Revenue by Countries

6.1 Europe Sleep Disorder Therapeutics Revenue by Countries (2013-2018)

6.2 Germany Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

6.3 UK Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

6.4 France Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

6.5 Russia Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

6.6 Italy Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Sleep Disorder Therapeutics Revenue by Countries

7.1 Asia-Pacific Sleep Disorder Therapeutics Revenue by Countries (2013-2018)

7.2 China Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

7.3 Japan Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

7.4 Korea Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

7.5 India Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Sleep Disorder Therapeutics Revenue by Countries

8.1 South America Sleep Disorder Therapeutics Revenue by Countries (2013-2018)

8.2 Brazil Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

8.3 Argentina Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

8.4 Colombia Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Sleep Disorder Therapeutics by Countries

9.1 Middle East and Africa Sleep Disorder Therapeutics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

9.3 UAE Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

9.4 Egypt Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

9.6 South Africa Sleep Disorder Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Sleep Disorder Therapeutics Market Segment by Type

10.1 Global Sleep Disorder Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Global Sleep Disorder Therapeutics Market Forecast by Type (2018-2023)

10.3 Insomnia Revenue Growth Rate (2013-2023)

10.4 Excessive Sleep Revenue Growth Rate (2013-2023)

10.5 Disturbed Sleep Revenue Growth Rate (2013-2023)

11 Global Sleep Disorder Therapeutics Market Segment by Application

11.1 Global Sleep Disorder Therapeutics Revenue Market Share by Application (2013-2018)

11.2 Sleep Disorder Therapeutics Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacies Revenue Growth (2013-2018)

11.4 Online Pharmacies Revenue Growth (2013-2018)

11.5 Retail Pharmacies Revenue Growth (2013-2018)

12 Global Sleep Disorder Therapeutics Market Size Forecast (2018-2023)

12.1 Global Sleep Disorder Therapeutics Market Size Forecast (2018-2023)

12.2 Global Sleep Disorder Therapeutics Market Forecast by Regions (2018-2023)

12.3 North America Sleep Disorder Therapeutics Revenue Market Forecast (2018-2023)

12.4 Europe Sleep Disorder Therapeutics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Sleep Disorder Therapeutics Revenue Market Forecast (2018-2023)

12.6 South America Sleep Disorder Therapeutics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Sleep Disorder Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Sleep Disorder Therapeutics Picture

Table Product Specifications of Sleep Disorder Therapeutics

Table Global Sleep Disorder Therapeutics and Revenue (Million USD) Ma

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery